Zai Lab raises $250M PIPE for ADC development
Alpha Vantage · StreetInsider · · AI-summarised by FinFlash
Zai Lab secured roughly $250 million in PIPE financing, selling 11,340,000 American Depositary Shares at $22.04 each. TCGX led the deal alongside several other prominent investment firms. Proceeds will mainly fund global development of zocilurtatug pelitecan, its DLL3-targeting antibody-drug conjugate. The transaction is expected to close around October 27, 2026.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.